Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Medtronic
Johnson and Johnson
Dow
Mallinckrodt

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Patent: 8,318,791

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,318,791
Title:Substituted imidazole derivatives
Abstract: The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: ##STR00001##
Inventor(s): Wang; Weibo (Moraga, CA), Barsanti; Paul A. (Pleasant Hill, CA), Xia; Yia (Palo Alto, CA), Boyce; Rustum (Singapore, SG), Pecchi; Sabina (Oakland, CA), Brammeier; Nathan (Walnut Creek, CA), Phillips; Megan C. (Walnut Creek, CA), Mendenhall; Kris (Concord, CA), Wayman; Kelly (San Rafael, CA), Lagniton; Liana Marie (Berkeley, CA), Constantine; Ryan (Salt Lake City, UT), Yang; Hong (Pleasant Hill, CA), Mieuli; Elizabeth (Oakland, CA), Ramurthy; Savithri (Walnut Creek, CA), Jazan; Elisa (Richmond, CA), Sharma; Anu (El Cerrito, CA), Jain; Rama (Fremont, CA), Subramanian; Sharadha (San Ramon, CA), Renhowe; Paul A. (Danville, CA), Bair; Kenneth W. (Oakland, CA), Duhl; David (Oakland, CA), Walter; Annette (Mill Valley, CA), Abrams; Tinya (Richmond, CA), Huh; Kay (San Mateo, CA), Martin; Eric (El Cerrito, CA), Knapp; Mark (Oakland, CA), Le; Vincent P. (San Francisco, CA)
Assignee: Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA)
Application Number:12/455,798
Patent Claims:see list of patent claims

Details for Patent 8,318,791

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28   Start Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-06-20 RX search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 002 2017-06-22   Start Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-06-20 RX Orphan search
Genentech Inc RITUXAN HYCELA rituximab; hyaluronidase (human recombinant) SOLUTION;SUBCUTANEOUS 761064 001 2017-06-22   Start Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-06-20 RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial Novartis Vaccines and Diagnostics, Inc. (Emeryville, CA) 2025-06-20 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Moodys
Dow
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.